Markus Steiner

10PUBLICATIONS
27CO-AUTHORS
NanomedicineCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 08, 2026
Loading of STING Agonist into Lipid Nanoparticles Boosts Dendritic Cell Activation.

Ana Rs Ribeiro, Ander Eguskiza, Hieu-Hoa Dang

|Oct 28, 2023
Unraveling Resistance to Immunotherapy in MSI-High Colorectal Cancer.

Ronald Heregger, Florian Huemer, Markus Steiner

|Sep 10, 2021
A POLE Splice Site Deletion Detected in a Patient with Biclonal CLL and Prostate Cancer: A Case Report.

Markus Steiner, Franz J Gassner, Thomas Parigger

|Jul 02, 2021
Evidence for Non-Cancer-Specific T Cell Exhaustion in the Tcl1 Mouse Model for Chronic Lymphocytic Leukemia.

Thomas Parigger, Franz Josef Gassner, Christian Scherhäufl

|Jun 02, 2021
AID Contributes to Accelerated Disease Progression in the TCL1 Mouse Transplant Model for CLL.

Maria Schubert, Franz Josef Gassner, Michael Huemer

|Apr 03, 2021
Selective Activation of CNS and Reference PPARGC1A Promoters Is Associated with Distinct Gene Programs Relevant for Neurodegenerative Diseases.

Markus Kwik, Stefan Hainzl, Jan Oppelt

Pageof 2